β2 Adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats

Journal of Neurosurgical Anesthesiology

Volumn 24, Issue 1, 2012, Pages 30-38

  Zlotnik, Alexander ^a   Klin, Yael ^b   Gruenbaum, Benjamin Fredrick ^a   Gruenbaum, Shaun Evan ^c   Ohayon, Sharon ^a   Leibowitz, Akiva ^a   Kotz, Ruslan ^a   Dubilet, Michael ^a   Boyko, Matthew ^a   Shapira, Yoram ^a   Teichberg, Vivian I ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 adrenergic receptors; Glutamate; Recovery; Traumatic brain injury

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BUTOXAMINE; GLUTAMIC ACID; ISOPRENALINE; METOPROLOL; PROPRANOLOL;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; TRAUMATIC BRAIN INJURY;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN INJURIES; BUTOXAMINE; GLUTAMIC ACID; HEAD INJURIES, CLOSED; HEART RATE; HEMODYNAMICS; ISOPROTERENOL; MALE; METOPROLOL; MOVEMENT; NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; TREATMENT OUTCOME;

EID: 84857038573     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e318232deaa     Document Type: Article

References (54)

1. Krug EG, Sharma GK, Lozano R. The global burden of injuries. Am J Public Health. 2000;90:523-526. (Pubitemid 30167408)
2. Waxweiler RJ, Thurman D, Sniezek J, et al. Monitoring the impact of traumatic brain injury: a review and update. J Neurotrauma. 1995;12:509-516.
3. Rutland-Brown W, Langlois JA, Thomas KE, et al. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006;21:544-548. (Pubitemid 44813644)
4. Laurer HL, Lenzlinger PM, McIntosh TK. Models of traumatic brain injury. Eur J Trauma. 2000;26:95-100.
5. Castillo J, Davalos A, Naveiro J, et al. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060-1065. (Pubitemid 26177607)
6. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. The Lancet. 1997;349:79-83. (Pubitemid 27023423)
7. Johnston MV, Trescher WH, Ishida A, et al. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res. 2001; 49:735-741. (Pubitemid 32522044)
8. Zauner A, Bullock R, Kuta AJ, et al. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl. 1996;67:40-44. (Pubitemid 126446200)
9. Ferrarese C, Aliprandi A, Tremolizzo L, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 2001;57:671-675. (Pubitemid 32782996)
10. Shaw PJ, Forrest V, Ince PG, et al. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration. 1995;4:209-216.
11. Spranger M, Krempien S, Schwab S, et al. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci. 1996;143: 126-131. (Pubitemid 26402798)
12. Koura SS, Doppenberg EM, Marmarou A, et al. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998;71:244-246. (Pubitemid 128444409)
13. Zhang H, Zhang X, Zhang T, et al. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clin Chem. 2001;47:1458-1462.
14. Zlotnik A, Klin Y, Kotz R, et al. Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism. Exp Neurol. 2010;224:465-471.
15. Zlotnik A, Klin Y, Gruenbaum BF, et al. The activation of beta2-adrenergic receptors in naive rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection. Neurochem Res. 2011;36:732-738.
16. Graham LT Jr. Aprison MH. Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods. Anal Biochem. 1966;15:487-497.
17. Shapira Y, Shohami E, Sidi A, et al. Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit Care Med. 1988;16:258-265. (Pubitemid 18081907)
18. Schneider AM, Koven NS, Lombardo KA, et al. Beta-adrenergic receptor blockade by propranolol enhances retention in a multitrial passive-avoidance procedure. Behav Neurosci. 2000;114:1256-1260. (Pubitemid 32001906)
19. Sharma AB, Barlow MA, Yang SH, et al. Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation. 2008;76:108-119. (Pubitemid 350235064)
20. Keenan D, Romani A, Scarpa A. Differential regulation of circulating Mg2+ in the rat by beta 1- and beta 2-adrenergic receptor stimulation. Circ Res. 1995;77:973-983.
21. Zlotnik A, Klin Y, Kotz R, et al. Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism. Exp Neurol. 2010;224:465-471.
22. Palmer AM, Marion DW, Botscheller ML, et al. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem. 1993;61:2015-2024. (Pubitemid 23354056)
23. Richards DA, Tolias CM, Sgouros S, et al. Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: a clinical microdialysis study in children. Pharmacol Res. 2003;48: 101-109. (Pubitemid 36593365)
24. Faden AI, Demediuk P, Panter SS, et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244:798-800. (Pubitemid 19163864)
25. Stoffel M, Plesnila N, Eriskat J, et al. Release of excitatory amino acids in the penumbra of a focal cortical necrosis. J Neurotrauma. 2002;19:467-477. (Pubitemid 34412054)
26. Zlotnik A, Gurevich B, Tkachov S, et al. Brain neuroprotection by scavenging blood glutamate. Exp Neurol. 2007;203:213-220. (Pubitemid 44821179)
27. Martin SW, Broadley KJ. Relative resistance of functional beta2- adrenoceptor-mediated smooth muscle responses to in vitro desensitization. Can J Physiol Pharmacol. 1999;77:156-165. (Pubitemid 29342837)
28. Zlotnik A, Gurevich B, Cherniavsky E, et al. The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res. 2008;33:1044-1050.
29. Zlotnik A, Gruenbaum SE, Artru AA, et al. The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate. J Neurosurg Anesthesiol. 2009;21:235-241.
30. Berger C, Stauder A, Xia F, et al. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol. 2008;210:543-548.
31. Farooque M, Hillered L, Holtz A, et al. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis. J Neurotrauma. 1996;13:537-548. (Pubitemid 26366882)
32. Guyot LL, Diaz FG, O'Regan MH, et al. Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model. Neurosci Lett. 2001;299:37-40. (Pubitemid 32146339)
33. Han F, Shioda N, Moriguchi S, et al. Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolism. Neurosci Lett. 2008;430:275-280.
34. Zhang Y, Zhang H, Feustel PJ, et al. DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra. Exp Neurol. 2008;210:514-520.
35. Culmsee C. Targeting beta2-adrenoceptors for neuroprotection after cerebral ischemia: is inhibition or stimulation best? Anesth Analg. 2009;108:3-5.
36. Culmsee C, Junker V, Kremers W, et al. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke. 2004;35:1197-1202. (Pubitemid 38543543)
37. Culmsee C, Junker V, Thal S, et al. Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia. Eur J Pharmacol. 2007;575:57-65. (Pubitemid 47576070)
38. Culmsee C, Semkova I, Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int. 1999;35:47-57. (Pubitemid 29251228)
39. Junker V, Becker A, Huhne R, et al. Stimulation of betaadrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol. 2002;446:25-36. (Pubitemid 34722554)
40. Zhu Y, Culmsee C, Roth-Eichhorn S, et al. Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience. 2001;107:593-602. (Pubitemid 33100021)
41. Zhu Y, Culmsee C, Semkova I, et al. Stimulation of beta2- adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab. 1998;18:1032-1039. (Pubitemid 28427871)
42. Zhu Y, Prehn JH, Culmsee C, et al. The beta2-adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience. 1999;90: 1255-1263. (Pubitemid 29170143)
43. Semkova I, Schilling M, Henrich-Noack P, et al. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 1996;717:44-54. (Pubitemid 26153435)
44. Goyagi T, Kimura T, Nishikawa T, et al. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats. Anesth Analg. 2006;103:658-663. (Pubitemid 44542920)
45. Iwata M, Inoue S, Kawaguchi M, et al. Posttreatment but not pretreatment with selective beta-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia. Anesth Analg. 2010;110:1126-1132.
46. Ley EJ, Park R, Dagliyan G, et al. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010;68:353-356.
47. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, et al. Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience. 2009;158: 301-308.
48. Gottlieb M, Wang Y, Teichberg VI. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem. 2003;87:119-126. (Pubitemid 37210646)
49. Brown DR, Brown MJ. Hypoglycemia associated with preoperative metoprolol administration. Anesth Analg. 2004;99:1427-1428; table of contents. (Pubitemid 39407292)
50. Motomura S, Reinhard-Zerkowski H, Daul A, et al. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J. 1990;119:608-619. (Pubitemid 20098493)
51. ZLOTNIK A, KLIN Y, KOTZ R, et al. Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism. Exp Neurol. 2010;224:465-471.
52. Rosner MJ, Newsome HH, Becker DP. Mechanical brain injury: the sympathoadrenal response. J Neurosurg. 1984;61:76-86. (Pubitemid 14081296)
53. Clifton GL, Ziegler MG, Grossman RG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery. 1981;8:10-14. (Pubitemid 11146124)
54. Woolf PD, Hamill RW, Lee LA, et al. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66:875-882. (Pubitemid 17085709)